Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for 4202.T and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 4202.T and 80,000+ other tickers.
See exactly how 4202.T's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4202.T and 80,000+ other tickers.
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol…
No recent news available.